The following is a summary of “Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small ...

GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...

Monjuvi plus Revlimid and Rituxan demonstrated improved progression-free survival for patients with relapsed or refractory ...

CURE® highlights some of the top stories from SABCS, including those focused on older and younger patients with breast cancer ...

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical has announced positive results from its Phase III study of ...

Dr Suchitra Sundaram reflects on how ASH updates will address her patients' questions about the value of MRD testing in CLL treatment.

AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...

Results of a retrospective study of a racially diverse population demonstrated positive outcomes for patients with NSCLC who experience irAEs when treated with immune checkpoint inhibitors.

Addition of the CDK 4/6 inhibitor improved progression-free survival by 15.2 months for patients with HR+/HER2+ advanced ...

This page includes links to articles highlighting the top hematologic cancer research published on Cancer Therapy Advisor in ...

British drug maker AstraZeneca Plc (AZN.L, AZN) announced Monday that the European Commission has approved Tagrisso (osimertinib) to ...

In this exclusive MedPage Today video, Sonja Zweegman, MD, PhD, of Amsterdam University Medical Center in the Netherlands, ...